The field of clinical data is evolving at an unprecedented pace. The rise of digital health technologies such as sensors, wearables, electronic patient diaries and smartphone apps puts clinical data management at the forefront of healthcare and life sciences innovation. Research suggests that data points in phase III trials alone have increased threefold in the last 10 years to an average of 3.6 million. Unfortunately, insufficient infrastructure and data management processes are failing to address present and future challenges effectively, and simply increasing staff will not solve the problem. 

Life sciences companies are racing to harness the power of progress in clinical data science, investing in technology and reskilling to make faster, better decisions. Data management teams are leveraging more automation and analytics and using artificial intelligence to mine data and create more actionable insights. But as the power and value of data increases, what can be done to ensure it is being managed efficiently and responsibly?

This Financial Times webinar, held in partnership with Medidata, will explore how adjusting processes, utilising technology solutions and adapting workforces can improve clinical data management and deal with the ever-growing amount of information being collected. 

Understand

The big picture, not just the individual strands of the business you work in

Connect

And build relationships with some of the biggest names in your industry

Discover

New approaches, strategies and the future of clinical data management

Premier Digital Events Supported by the World's Best Journalism

Using leading digital technology, we have now taken our content, global audience reach and engagement to a new level through a series of unmissable virtual events. Our compelling events are chaired by respected FT journalists, feature the most senior and thought-provoking decision-makers in business, finance and politics, all accessible from your office or home.

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice